Therefore, calculating the immunophenotype from PD-L1 is oversimple, and several studies have confirmed that the signatures related to intra-tumor immune infiltration can effectively predict the response to immunotherapy (Teng et al., 2015; Ock et al., 2016). This evidence concerns the gene CD274 and neoplasm.